Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer
Open Access
- 31 December 1997
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 67 (3) , 272-276
- https://doi.org/10.1006/gyno.1997.4878
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Phase I Study of Paclitaxel and Cyclophosphamide in Recurrent Adenocarcinoma of the OvaryGynecologic Oncology, 1996
- Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian CancerJNCI Journal of the National Cancer Institute, 1994
- Patterns of care in carcinoma of the ovaryCancer, 1993
- Rapid Delivery of Multiple High-Dose Chemotherapy Courses With Granulocyte Colony-Stimulating Factor and Peripheral Blood-Derived Hematopoietic Progenitor CellsJNCI Journal of the National Cancer Institute, 1992
- Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.Journal of Clinical Oncology, 1992
- Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor PrognosisNew England Journal of Medicine, 1987
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977